Cochrane Evidence Synthesis and Methods ►

Nifuratel-Nystatin combination for the treatment of mixed infections of bacterial vaginosis, vulvovaginal candidiasis, and trichomonal vaginitis

To assess the effectiveness and safety of nifuratel-nystatin combination for the treatment of mixed infections of bacterial vaginosis, vulvovaginal candidiasis, and trichomonal vaginitis in women.

This is a protocol.

Health topics:

Infectious disease > Sexually transmitted disease > Trichomoniasis

Infectious disease > Sexually transmitted disease > Vaginal candidiasis (thrush)

Infectious disease > Sexually transmitted disease > Vaginosis

Reproductive & sexual health > Sexually transmitted infections > Trichomoniasis

Reproductive & sexual health > Sexually transmitted infections > Vaginal candidiasis (thrush)

Reproductive & sexual health > Sexually transmitted infections > Vaginosis

Published:

19 April 2018

Authors:

Obiero J, Rulisa S, Ogongo P, Wiysonge CS

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Obiero J, Rulisa S, Ogongo P, Wiysonge CS. Nifuratel-Nystatin combination for the treatment of mixed infections of bacterial vaginosis, vulvovaginal candidiasis, and trichomonal vaginitis. Cochrane Database of Systematic Reviews 2018, Issue 4. Art. No.: CD013012. DOI: 10.1002/14651858.CD013012